Whereas ATM inhibition alone had little effect on tumor growth, EGFR inhibitor monotherapy suppressed the growth of tumors before eventually giving rise to resistance outgrowth (Fig. 4A–4B). The gene discussed is EGFR; the disease is neoplasm.